Ignite Creation Date:
2025-12-25 @ 2:44 AM
Ignite Modification Date:
2025-12-30 @ 5:30 PM
Study NCT ID:
NCT00971633
Status:
COMPLETED
Last Update Posted:
2016-09-14
First Post:
2009-09-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Bioequivalence Study of 3 Formulations of Ondansetron in Healthy Adults (0869-095)(COMPLETED)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-11
Start Date Type:
None
Primary Completion Date:
2003-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-01
Completion Date Type:
ACTUAL
First Submit Date:
2009-09-03
First Submit QC Date:
None
Study First Post Date:
2009-09-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-07-30
Results First Submit QC Date:
None
Results First Post Date:
2010-08-26
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-09-13
Last Update Post Date:
2016-09-14
Last Update Post Date Type:
ESTIMATED